(19)
(11) EP 4 561 619 A1

(12)

(43) Date of publication:
04.06.2025 Bulletin 2025/23

(21) Application number: 23748062.9

(22) Date of filing: 26.07.2023
(51) International Patent Classification (IPC): 
A61K 39/12(2006.01)
C12N 15/63(2006.01)
C07K 16/28(2006.01)
A61K 39/00(2006.01)
 C07K 14/005(2006.01)
A61P 35/00(2006.01)
C12N 15/86(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 39/12; A61K 2039/53; A61K 2039/585; A61P 35/00; C07K 14/005; C07K 16/2818; C12N 15/86; C12N 2710/20022; C12N 2710/20034; C12N 2740/16043; C07K 16/2803
(86) International application number:
PCT/EP2023/070672
(87) International publication number:
WO 2024/023135 (01.02.2024 Gazette 2024/05)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 27.07.2022 EP 22306119

(71) Applicants:
  • Theravectys
    75015 Paris (FR)
  • Institut Pasteur
    75015 Paris (FR)

(72) Inventors:
  • CHARNEAU, Pierre
    75015 Paris (FR)
  • ANNA, François
    75015 Paris (FR)
  • MONCOQ, Fanny
    75015 Paris (FR)
  • NOIRAT, Amandine
    75015 Paris (FR)
  • LALEH, Majlessi
    75015 Paris (FR)
  • DOUGUET, Laetitia
    75015 Paris (FR)
  • FERT, Ingrid
    75015 Paris (FR)

(74) Representative: Cabinet Nony 
11 rue Saint-Georges
75009 Paris
75009 Paris (FR)

   


(54) LENTIVIRAL VECTORS FOR EXPRESSION OF HUMAN PAPILLOMAVIRUS (HPV) ANTIGENS AND ITS IMPLEMENTATION IN THE TREATMENT OF HPV INDUCED CANCERS